Clinical Trial Update: Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence

View source ↗

Summary

A clinical trial investigating detection of cancer-specific active proteases in blood using fluorescence for pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Kansas | Conditions: Pancreatic Cancer | Status: WITHDRAWN